Option chain shows key data for UpHealth's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for UpHealth.

UpHealth (OTC:UPHL) Stock, Option Chain

UpHealth Inc is a digital health company intent on creating a single, integrated platform of technologies and services essential to personalized, affordable, and effective care globally. The company's segment includes Integrated Care Management; Virtual Care Infrastructure; Services and Corporate. It generates maximum revenue from the Services segment. Geographically, it derives a majority of its revenue from the Americas.

UpHealth Inc

Arm Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) shares are trading lower, likely due to continued weakness stemming from its ongoing legal dispute with Qualcomm Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>), which began on Tuesday, Dec. 16 2024. Here&#8217;s <a href="https://www.benzinga.com/quote/ARM/news">what you need to know.</a>
What To Know: The case centers on Qualcomm's 2021 acquisition of Nuvia, a chip startup and the licensing agreements Arm had with Nuvia prior to the acquisition. Arm contends that the deal with Qualcomm requires renegotiation and is seeking to have Qualcomm destroy certain chip designs obtained through the Nuvia acquisition. Qualcomm, on the other hand, maintains that it has its own licensing agreements with Arm, separate from those held by Nuvia, and that it has paid for the necessary intellectual property.
This legal battle between two of the largest players in the chip industry is attracting attention, as it could impact the future business dealings between Arm and Qualcomm and the broader technology sector. The case also highlights the growing rivalry between the two companies. Arm, which traditionally provided chip designs and licenses to other companies, has been moving to become more of a chip supplier itself, putting it in direct competition with Qualcomm.
The trial is expected to last a week and could result in a shift in the licensing fees Qualcomm may need to pay to Arm. While some analysts predict a settlement, Qualcomm's track record in patent litigation may be adding an element of uncertainty. The case is potentially seen as a crucial moment for both companies, with potential consequences for their future business strategies and the broader chip industry. 
ARM Price Action: Arm Holdings shares were down 2.01% at $141.97 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard">Benzinga pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://benzinga.slack.com/archives/D072651PB4K/p1733167806337199"><img loading="lazy" decoding="async" width="1024" height="525" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17135512/ARM-1024x525.png" alt="" class="wp-image-696417" style="width:523px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17135512/ARM-1024x525.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17135512/ARM-300x154.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17135512/ARM-768x394.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17135512/ARM.png 1183w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42537434/meta-fined-264-million-over-2018-facebook-data-breach-in-europe">Meta Fined $264 Million By EU Watchdog Over 2018 Facebook Data Breach</a></li>
</ul>
Image via Shutterstock.

News

Movers

QCOM

Arm Holdings Shares Are Down Today: What You Need To Know

Wells Fargo analyst Daniel Politzer maintains Life Time Group Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LTH#NYSE">LTH</a>) with a Equal-Weight and raises the price target from $25 to $26.

Price Target

Analyst Ratings

Wells Fargo Maintains Equal-Weight on Life Time Group Hldgs, Raises Price Target to $26

UBS analyst Nicholas Holowko assumes Comerica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) with a Sell rating and raises Price Target to $64.

Initiation

UBS Assumes Comerica at Sell, Raises Price Target to $64

The newly-launched Pudgy Penguins (CRYPTO: PENGU) token has been listed on Binance, prompting speculation that it could soon join the ranks of the <a href="https://www.benzinga.com/money/top-meme-coins">top meme coins</a>.
What Happened: According to Lookonchain <a href="https://x.com/lookonchain/status/1869013028236410900">data</a>, a savvy trader made $8.4 million profit by trading PENGU in under 20 minutes. 
At launch, the trader spent 23,742 SOL ($5.36 million) to purchase 239.6 million PENGU tokens, later selling them for 60,726 SOL ($13.72 million), netting a massive gain of 36,984 SOL.
In stark contrast, another trader <a href="https://x.com/bx1core/status/1869012514551611662">experienced</a> a devastating loss. By making a poorly timed trade on PENGU, they managed to turn $10,000 into a mere $5 in just seconds.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>Pudgy Penguins (CRYPTO: PENGU)</td>
<td>$0.03354</td>
<td>$2.09 billion</td>
<td>+570%</td>
<td>NA</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.3981</td>
<td>$58.6 billion</td>
<td>-2.2%</td>
<td>+3.9%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00002688&nbsp;</td>
<td>$15.8 billion</td>
<td>-2.6%</td>
<td>+5.7%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Crypto trader Wizard of SoHo highlighted the potential of PENGU, predicting it will eventually sit between Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) and Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>). 
In a <a href="https://x.com/wizardofsoho/status/1869059788505759930">tweet</a>, he praised Pudgy Penguins&#8217; strategy, noting their ability to onboard &#8220;millions of wallets into a fun meme that will become a top 10 coin.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Doge is $59B Shib is $16B Pepe is $9.8B Pengu will be in between Shib and Doge eventually
&mdash; Wizard Of SoHo (&#x1f377;,&#x1f377;) (@wizardofsoho) <a href="https://twitter.com/wizardofsoho/status/1869062801916133785?ref_src=twsrc%5Etfw">December 17, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Similarly, trader Kaleo <a href="https://x.com/CryptoKaleo/status/1869026981859213405">expressed</a> bullish sentiment, speculating on PENGU's potential to grow its market cap from the current $2.1 billion to $8.5 billion, bridging the gap to major meme coins.
Prominent crypto trader Cold Blooded Shiller <a href="https://x.com/ColdBloodShill/status/1869082168951181518">disclosed</a> his recent investment in PENGU at a discount, stating his intent to hold for 12 months while waiting for &#8220;Abstract and DeFi developments.&#8221; 
He also mentioned accumulating PENGU on spot markets to lock it for the long term.
Community News: The Pudgy Penguins team celebrated the successful <a href="https://x.com/pudgypenguins/status/1869057237542654117">launch</a> of PENGU on Binance, OKX, and ByBit, following its initial release on Dec. 6.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/24/12/42496442/if-you-invested-1000-in-pudgy-penguins-nfts-at-mint-heres-how-much-youd-have-today">If You Invested $1,000 In Pudgy Penguins NFTs At Mint, Here&#8217;s How Much You&#8217;d Have Today</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$DOGE

$SHIB

Pudgy Penguin Token Launches At $2 Billion Valuation, Could Land 'Between Shiba Inu And Dogecoin,' Trader Says

WIIM

NMTC

NeuroOne Medical shares are trading higher after the company reported a year-over-year increase in FY24 annual results and issued expectations for a year-over-year increase in its FY25 product revenue guidance.

Financial giants have made a conspicuous bearish move on DraftKings. Our analysis of options history for DraftKings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>) revealed 18 unusual trades.
Delving into the details, we found 33% of traders were bullish, while 55% showed bearish tendencies. Out of all the trades we spotted, 8 were puts, with a value of $490,294, and 10 were calls, valued at $417,418.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $35.0 and $55.0 for DraftKings, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for DraftKings's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across DraftKings's significant trades, within a strike price range of $35.0 to $55.0, over the past month.
<h3>DraftKings Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734464733_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>DKNG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$3.3</td>
<td>$3.2</td>
<td>$3.3</td>
<td>$40.00</td>
<td>$247.5K</td>
<td>588</td>
<td>751</td>
</tr>
<tr>
<td>DKNG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$0.68</td>
<td>$0.67</td>
<td>$0.67</td>
<td>$40.00</td>
<td>$66.3K</td>
<td>8.3K</td>
<td>4.0K</td>
</tr>
<tr>
<td>DKNG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$5.7</td>
<td>$5.6</td>
<td>$5.62</td>
<td>$41.00</td>
<td>$56.2K</td>
<td>471</td>
<td>220</td>
</tr>
<tr>
<td>DKNG</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>05/16/25</td>
<td>$5.75</td>
<td>$5.4</td>
<td>$5.6</td>
<td>$38.00</td>
<td>$50.3K</td>
<td>528</td>
<td>90</td>
</tr>
<tr>
<td>DKNG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$8.55</td>
<td>$8.4</td>
<td>$8.4</td>
<td>$35.00</td>
<td>$46.2K</td>
<td>120</td>
<td>56</td>
</tr>
</tbody>
</table>

<h3>About DraftKings</h3>
DraftKings got its start in 2012 as an innovator in daily fantasy sports. Then, following a Supreme Court ruling in 2018 that allowed states to legalize online sports wagering, the company expanded into online sports and casino gambling, where it generally holds the number two or three revenue share position across states in which it competes. DraftKings is now live with online or retail sports betting in about 30 states and iGaming in seven states, with both products available to around 40% of Canada's population. The company also operates a non-fungible token commissioned-based marketplace and develops and licenses online gaming products.
In light of the recent options history for DraftKings, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>DraftKings's Current Market Status</h3>
<ul>
<li>Trading volume stands at 8,972,409, with DKNG's price down by -0.66%, positioned at $38.98.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 58 days.</li>
</ul>
<h3>What The Experts Say On DraftKings</h3>
1 market experts have recently issued ratings for this stock, with a consensus target price of $53.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from JP Morgan continues to hold a Overweight rating for DraftKings, targeting a price of $53. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for DraftKings, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

DKNG

Looking At DraftKings's Recent Unusual Options Activity

Financial giants have made a conspicuous bearish move on MongoDB. Our analysis of options history for MongoDB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) revealed 79 unusual trades.
Delving into the details, we found 22% of traders were bullish, while 62% showed bearish tendencies. Out of all the trades we spotted, 13 were puts, with a value of $667,719, and 66 were calls, valued at $4,451,028.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $115.0 to $600.0 for MongoDB over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for MongoDB's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across MongoDB's significant trades, within a strike price range of $115.0 to $600.0, over the past month.
<h3>MongoDB Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734464728_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MDB</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$10.8</td>
<td>$10.15</td>
<td>$10.4</td>
<td>$280.00</td>
<td>$624.0K</td>
<td>1.7K</td>
<td align="right">784</td>
</tr>
<tr>
<td>MDB</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$21.9</td>
<td>$21.4</td>
<td>$21.4</td>
<td>$390.00</td>
<td>$226.9K</td>
<td>10</td>
<td align="right">112</td>
</tr>
<tr>
<td>MDB</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$68.3</td>
<td>$64.5</td>
<td>$64.5</td>
<td>$270.00</td>
<td>$187.0K</td>
<td>171</td>
<td align="right">29</td>
</tr>
<tr>
<td>MDB</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$93.05</td>
<td>$92.2</td>
<td>$92.2</td>
<td>$210.00</td>
<td>$175.2K</td>
<td>25</td>
<td align="right">21</td>
</tr>
<tr>
<td>MDB</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>02/21/25</td>
<td>$14.65</td>
<td>$14.2</td>
<td>$14.41</td>
<td>$290.00</td>
<td>$144.1K</td>
<td>250</td>
<td align="right">8</td>
</tr>
</tbody>
</table>

<h3>About MongoDB</h3>
Founded in 2007, MongoDB is a document-oriented database. MongoDB provides both licenses as well as subscriptions as a service for its NoSQL database. MongoDB's database is compatible with all major programming languages and is capable of being deployed for a variety of use cases.
In light of the recent options history for MongoDB, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>MongoDB's Current Market Status</h3>
<ul>
<li>With a trading volume of 1,078,933, the price of MDB is up by 0.52%, reaching $267.0.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 79 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for MongoDB</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $401.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Loop Capital has decided to maintain their Buy rating on MongoDB, which currently sits at a price target of $400. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on MongoDB, which currently sits at a price target of $425. 
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Overweight rating on MongoDB with a target price of $400. 
&#x2A; Consistent in their evaluation, an analyst from Citigroup keeps a Buy rating on MongoDB with a target price of $430. 
&#x2A; Reflecting concerns, an analyst from Rosenblatt lowers its rating to Buy with a new price target of $350.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for MongoDB, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

What the Options Market Tells Us About MongoDB

Whales with a lot of money to spend have taken a noticeably bullish stance on Astera Labs.
Looking at options history for Astera Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>) we detected 9 trades.
If we consider the specifics of each trade, it is accurate to state that 44% of the investors opened trades with bullish expectations and 33% with bearish.
From the overall spotted trades, 3 are puts, for a total amount of $175,633 and 6, calls, for a total amount of $291,290.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $60.0 to $155.0 for Astera Labs over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Astera Labs's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Astera Labs's whale activity within a strike price range from $60.0 to $155.0 in the last 30 days. 
<h3>Astera Labs Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734464723_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ALAB</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$4.2</td>
<td>$4.1</td>
<td>$4.1</td>
<td>$150.00</td>
<td>$123.1K</td>
<td>504</td>
<td>789</td>
</tr>
<tr>
<td>ALAB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$1.25</td>
<td>$0.95</td>
<td>$1.2</td>
<td>$60.00</td>
<td>$114.6K</td>
<td>108</td>
<td>2.3K</td>
</tr>
<tr>
<td>ALAB</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$15.2</td>
<td>$15.0</td>
<td>$15.2</td>
<td>$120.00</td>
<td>$38.0K</td>
<td>1.8K</td>
<td>72</td>
</tr>
<tr>
<td>ALAB</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$32.7</td>
<td>$31.3</td>
<td>$32.11</td>
<td>$150.00</td>
<td>$35.3K</td>
<td>15</td>
<td>11</td>
</tr>
<tr>
<td>ALAB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$36.5</td>
<td>$34.9</td>
<td>$34.9</td>
<td>$115.00</td>
<td>$35.0K</td>
<td>31</td>
<td>10</td>
</tr>
</tbody>
</table>

<h3>About Astera Labs</h3>
Astera Labs Inc is a company that offers an Intelligent Connectivity Platform, comprised of Semiconductor-based, high-speed mixed-signal connectivity products that integrate a matrix of microcontrollers and sensors. COSMOS, their software suite which is embedded in its connectivity products and integrated into their customers' systems. The Company delivers critical connectivity performance, enables flexibility and customization, and supports observability and predictive analytics. This approach addresses the data, network, and memory bottlenecks, scalability, and other infrastructure requirements of hyperscalers and system original equipment manufacturers.
<h3>Current Position of Astera Labs</h3>
<ul>
<li>Currently trading with a volume of 2,769,496, the ALAB's price is down by -1.0%, now at $129.17. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 97 days.</li>
</ul>
<h3>What The Experts Say On Astera Labs</h3>
In the last month, 1 experts released ratings on this stock with an average target price of $120.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from Citigroup lowers its rating to Buy with a new price target of $120.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Astera Labs options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

ALAB

This Is What Whales Are Betting On Astera Labs

DUOT

Duos Technologies shares are trading higher after Ascendiant Capital maintained a Buy rating on the stock and raised its price target from $6 to $7.5.

LPTH

LightPath Technologies shares are trading higher after the company highlighted strategy changes including shifts towards avenues like advanced optics and imaging systems, defense growth, and black diamond glass innovation.

UBS analyst Nicholas Holowko assumes Zions Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZION#NASDAQ">ZION</a>) with a Neutral rating and announces Price Target of $64.

ZION

UBS Assumes Zions Bancorp at Neutral, Announces Price Target of $64

UBS analyst Nicholas Holowko assumes Popular (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPOP#NASDAQ">BPOP</a>) with a Neutral rating and announces Price Target of $104.

BPOP

UBS Assumes Popular at Neutral, Announces Price Target of $104

President Joe Biden has endorsed a ban on Congress Trading, suggesting that members of Congress should not be able to buy and sell stocks in options while they<a href="https://www.benzinga.com/topic/congress-trading"> are in office.</a>
What Happened: Congress Trading has been a popular topic among retail investors for years with <a href="https://www.benzinga.com/markets/options/24/10/41459593/nvidia-stock-hits-all-time-highs-heres-how-much-nancy-pelosis-500-call-options-are-worth-today">the trading activity </a>of former Speaker of the House Nancy Pelosi closely followed thanks to the often winning trades made by her husband Paul Pelosi.
Investors also monitor potential conflicts of interest trades, such as Congress members <a href="https://www.benzinga.com/general/politics/24/04/38254235/congress-members-invest-in-defense-stocks-as-middle-east-tensions-mount-how-pelosi-gottheimer-he">buying war stocks</a> during increased Middle East tensions and which members of Congress are buying <a href="https://www.benzinga.com/markets/equities/24/12/42447434/democratic-congressman-bought-djt-stock-after-2024-election-months-after-saying-donald-trump-unfit-to-serve">Trump-linked stocks</a> and <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42330146/congressman-buys-meme-coins-ski-mask-dog-coin-climbs-in-value-after-disclosure-i-liked-the-coins-so-i-bought-them">meme coins.</a>
President Biden is calling for an end to the current legal practice.
"Nobody in the Congress should be able to make money in the stock market while they're in the Congress," Biden said in an interview with political advisor Faiz Shakir.
The video, which is set to be released later this week, will be published by A More Perfect Union, as <a href="https://apnews.com/article/joe-biden-congress-stock-trading-ban-dd9a17d7ea96a8f3a4705ebe1504c72d">reported </a>by the Associated Press, which was able to view the video ahead of its release.
Biden's comment comes as members of Congress are currently able to buy and sell stocks, options, and cryptocurrency as long as they properly disclose the trades within the appropriate time limit of 45 days.  
In the interview, Shakir said he admired the fact that Biden didn't get into stocks early like Google, Boeing, Microsoft, Nvidia and Amazon while he was a senator.
"I don't know how you look your constituents in the eye and know, because the job they gave you, gave you an inside track to make more money. I think we should be changing the law," Biden added.
Biden said he was able to live on a Congressional salary and not worry about becoming rich through playing the stock market previously.
The comments made in the interview mark a change in Biden's opinion on the issue. Biden previously refused to weigh in on the issue of congressional trading, saying he would "let members of leadership in Congress and members of Congress determine what the rules should be," as his previous press secretary Jen Psaki reported.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent121724">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Why It's Important: There have been numerous calls to vote for Congress members to vote for a ban on Congressional trading, but a vote has not happened.
Representative Ro Khanna (D-Calif.) <a href="https://www.benzinga.com/general/politics/24/05/39096827/exclusive-khanna-says-shameful-congress-members-profited-from-stocks-calls-for-trading-ban-makin">previously told Benzinga </a>that he will continue to advocate for a vote to ban the practice.
"We should have a vote on it," Khanna told Benzinga.
Khanna said that despite his continued speeches in the House advocating for a ban on stock trading, there is a "collective shrug" in Congress regarding the issue.
&#8220;It is shameful that over three years after the pandemic with the shenanigans from those senators who sold their stock after learning of the pandemic&#8221; there still hasn&#8217;t been a vote, Khanna said.
Khanna said that people were outraged at the time when several senators sold their stocks in tourism and other sectors that would be hurt, knowing that the economy could crash from the COVID-19 pandemic.
&#8220;Senators making money when the rest of the country was suffering during the pandemic.&#8221;
With Biden now advocating for the ban before the end of his presidential term, the situation will be closely monitored to see if Congress votes on the matter.
Unusual Whales helped<a href="https://www.benzinga.com/markets/penny-stocks/23/02/30768851/want-to-copy-master-trader-nancy-pelosis-investments-theres-an-etf-for-that-here-are-the-hol" target="_blank" rel="noreferrer noopener">&nbsp;launch two Congress Trading themed ETFs&nbsp;</a>in 2023 through a collaboration with Subversive. The&nbsp;Unusual Whales Subversive Democratic Trading ETF&nbsp;(BATS:<a class="ticker" href="https://www.benzinga.com/stock/NANC#BATS">NANC</a>)&nbsp;and&nbsp;Unusual Whales Subversive Republican Trading ETF&nbsp;(BATS:<a class="ticker" href="https://www.benzinga.com/stock/KRUZ#BATS">KRUZ</a>)&nbsp;provide investors with opportunities to invest in the same stocks as members of Congress.
Benzinga will continue to share Congressional trading activity of note. For more on Congress trades, check out Benzinga&#8217;s&nbsp;<a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent121724" target="_blank" rel="noreferrer noopener">Government Trades page.</a>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/politics/24/01/36459015/10-best-stock-traders-in-congress-in-2023-spoiler-nancy-pelosi-is-back-on-the-list">10 Best Stock Traders In Congress In 2023 (Spoiler: Nancy Pelosi Has Reentered The Chat)</a></li>
</ul>
Photo by lev radin on Shutterstock

Politics

KRUZ

NANC

Biden Backs Congressional Stock Trading Ban: 'Inside Track' To Wealth

UBS analyst Vilas Abraham assumes Pinnacle Finl Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PNFP#NASDAQ">PNFP</a>) with a Neutral rating and raises Price Target to $133.

PNFP

UBS Assumes Pinnacle Finl Partners at Neutral, Raises Price Target to $133

Palantir Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) <a href="https://www.benzinga.com/quote/PLTR/news">stock surged</a> an eye-popping 350% year-to-date.
But just as retail investors celebrate their portfolios swelling, company insiders — including CFO David A. Glazer and CTO Shyam Sankar — are selling millions of dollars worth of shares.
What Happened: In December alone, Glazer sold $23 million worth of shares, while Sankar offloaded a staggering $367.9 million following an exercise of stock options. 
Even CEO Alex Karp joined the selling spree last month, cashing in $132.8 million worth of shares. Despite the eye-catching totals, these transactions represent a tiny fraction of their overall holdings.
So, are they losing faith — or just diversifying?
Read Also: <a href="https://www.benzinga.com/24/12/42520765/super-micro-drops-below-50-day-average-faces-nasdaq-100-removal-just-months-after-entry">Super Micro Drops Below 50-Day Average, Faces Nasdaq 100 Removal Just Months After Entry</a>
<h2 class="wp-block-heading">PLTR Stock&#8217;s Bullish Trend</h2>
From a technical perspective, Palantir&#8217;s stock seems unshakable. 
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121724&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="630" height="493" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17123528/Screenshot-2024-12-17-at-11.05.14-PM.png" alt="" class="wp-image-696232" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17123528/Screenshot-2024-12-17-at-11.05.14-PM.png 630w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17123528/Screenshot-2024-12-17-at-11.05.14-PM-300x235.png 300w" sizes="(max-width: 630px) 100vw, 630px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121724&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Chart created using Benzinga Pro</a>
It's trading well above its eight-day, 20-day, 50-day and 200-day moving averages, signaling robust bullish momentum. The Moving Average Convergence Divergence (MACD) indicator, at 5.30, screams &#8220;bullish.&#8221; 
Yet, the Relative Strength Index (RSI) is at 66.20, teetering on overbought territory.
What&#8217;s Next: The charts suggest the stock has more room to climb. But with the stock price 313% higher than a year ago, some are questioning how much gas is left in the tank.
So, should you ride the wave or cash in like the execs? While Palantir's future may still be dazzling, history shows insider selling is often a cue to exercise caution—or at least re-evaluate your risk appetite.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/12/42524611/jim-cramer-highlights-cult-stocks-like-tesla-palantir-netflix-as-2025-investment-strategy">Jim Cramer Highlights &#8216;Cult Stocks&#8217; Like Tesla, Palantir, Netflix As 2025 Investment Strategy</a></li>
</ul>
Image: Shutterstock

Technicals

Tech

Trading Ideas

PLTR

Palantir Rockets 350% Year-To-Date, Insiders Offload Stock: Should Retail Investors Follow?

UBS analyst Nicholas Holowko assumes Flagstar Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLG#NYSE">FLG</a>) with a Neutral rating and announces Price Target of $11.5.

UBS Assumes Flagstar Financial at Neutral, Announces Price Target of $11.5

JPMorgan analysts Jeremy Tonet and Richard W. Sunderland believe <a href="https://www.benzinga.com/topic/utilities">utilities in North America are gearing up</a> for a stellar 2025.
Bolstered by accelerating power demand and transformative growth drivers like electrification, data center expansion and manufacturing onshoring, utility stocks are positioned for sustained strength.
Their top picks from the space include Vistra Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>), Entergy Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETR#NYSE">ETR</a>), NiSource Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NI#NYSE">NI</a>) and PG&amp;E Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PCG#NYSE">PCG</a>). Here&#8217;s why each of these make a great 2025 pick.
<h1 class="wp-block-heading">1. Vistra</h1>
Vistra's Texas-sized opportunity makes it JPMorgan's top pick. 
The company boasts unmatched exposure to the Electric Reliability Council of Texas (ERCOT), a robust integrated retail business and a nuclear production tax credit upside via its Energy Harbor acquisition.
Vistra is uniquely positioned to benefit from soaring baseload demand, tightening power supply and favorable ERCOT pricing. With guidance forecasting double-digit EBITDA growth through 2026, Vistra's potential to secure gas plant contracts and capitalize on regional power price spikes keeps it in the "catbird seat."
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/24/11/41997342/appaloosa-hedge-fund-buys-vistra-sells-boeing">Appaloosa Hedge Fund Buys Vistra, Sells Boeing</a>
<h1 class="wp-block-heading">2. Entergy</h1>
Entergy has captured the spotlight with its recent data center deals, including Meta Platform Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) $10 billion investment in Louisiana.
JPMorgan highlights Entergy's ability to replicate such successes, driving load growth and industrial sales compound annual growth rates (CAGR). With surging Gulf Coast demand and replicable engagement frameworks, Entergy continues to outperform with rising earnings guidance and customer expansion.
<h1 class="wp-block-heading">3. NiSource</h1>
NiSource is riding the data center wave in the Midwest, with load scenarios pointing to significant generation needs. Its impressive 6%-8% annual EPS growth and 8%-10% rate base CAGR make it a standout mid-cap utility.
JPMorgan sees inflection potential for NiSource, especially with new load announcements expected to act as catalysts for an upward earnings revision in 2025.
<h1 class="wp-block-heading">4. PG&amp;E</h1>
PG&amp;E shines with its 10% EPS growth outlook and clear runway for financing, thanks to a recent equity raise. 
JPMorgan believes PG&amp;E's wildfire mitigation investments, data center pipeline and re-rating potential could drive substantial gains. Updates on its system investment needs in the fourth quarter are likely to serve as pivotal catalysts for growth in 2025 and beyond.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42289305/top-3-utilities-stocks-that-could-sink-your-portfolio-this-month">Top 3 Utilities Stocks That Could Sink Your Portfolio This Month</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Long Ideas

Commodities

Vistra, Entergy, NiSource, PG&E: 4 Utilities Power Up For Bullish 2025, Says JPMorgan

UBS analyst Nicholas Holowko assumes First Interstate BancSys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIBK#NASDAQ">FIBK</a>) with a Neutral rating and announces Price Target of $35.

FIBK

UBS Assumes First Interstate BancSys at Neutral, Announces Price Target of $35

Investors with significant funds have taken a bullish position in Freeport-McMoRan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>), a development that retail traders should be aware of.
This was brought to our attention today through our monitoring of publicly accessible options data at Benzinga. The exact nature of these investors remains a mystery, but such a major move in FCX usually indicates foreknowledge of upcoming events.
Today, Benzinga's options scanner identified 14 options transactions for Freeport-McMoRan. This is an unusual occurrence. The sentiment among these large-scale traders is mixed, with 50% being bullish and 42% bearish. Of all the options we discovered, 13 are puts, valued at $637,798, and there was a single call, worth $1,150,000.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $33.0 to $50.0 for Freeport-McMoRan during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Freeport-McMoRan's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Freeport-McMoRan's whale trades within a strike price range from $33.0 to $50.0 in the last 30 days. 
<h3>Freeport-McMoRan Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734463826_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>FCX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$2.3</td>
<td>$2.26</td>
<td>$2.3</td>
<td>$45.00</td>
<td>$1.1M</td>
<td>1.5K</td>
<td align="right">23</td>
</tr>
<tr>
<td>FCX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>02/21/25</td>
<td>$1.85</td>
<td>$1.82</td>
<td>$1.84</td>
<td>$39.00</td>
<td>$107.5K</td>
<td>4.9K</td>
<td align="right">589</td>
</tr>
<tr>
<td>FCX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$6.55</td>
<td>$6.5</td>
<td>$6.55</td>
<td>$47.00</td>
<td>$75.3K</td>
<td>4.7K</td>
<td align="right">195</td>
</tr>
<tr>
<td>FCX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$5.85</td>
<td>$5.75</td>
<td>$5.85</td>
<td>$45.00</td>
<td>$67.2K</td>
<td>10.6K</td>
<td align="right">116</td>
</tr>
<tr>
<td>FCX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$5.45</td>
<td>$5.15</td>
<td>$5.25</td>
<td>$40.00</td>
<td>$63.0K</td>
<td>6.5K</td>
<td align="right">120</td>
</tr>
</tbody>
</table>

<h3>About Freeport-McMoRan</h3>
Freeport-McMoRan owns stakes in 10 copper mines, led by its 49% ownership of the Grasberg copper and gold operations in Indonesia, 55% of the Cerro Verde mine in Peru, and 72% of Morenci in Arizona. It sold around 1.2 million metric tons of copper (its share) in 2023, making it the one of the world's largest copper miners by volume. It also sold about 900,000 ounces of gold, mostly from Grasberg, and 70 million pounds of molybdenum. About 75% of 2023 revenue was from copper, with a further 15% from gold and about 10% from molybdenum. It had about 25 years of copper reserves at end December 2023. we expect it to sell similar amounts of copper midcycle in 2028, though we expect gold volumes to decline to about 700,000 ounces then due to falling production at Grasberg.
After a thorough review of the options trading surrounding Freeport-McMoRan, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is Freeport-McMoRan Standing Right Now?</h3>
<ul>
<li>With a volume of 6,522,648, the price of FCX is down -1.45% at $40.15. </li>
<li>RSI indicators hint that the underlying stock may be approaching oversold.</li>
<li>Next earnings are expected to be released in 36 days.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Freeport-McMoRan options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Market Whales and Their Recent Bets on FCX Options

Investors with a lot of money to spend have taken a bearish stance on Humana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with HUM, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 54 uncommon options trades for Humana.
This isn't normal.
The overall sentiment of these big-money traders is split between 40% bullish and 50%, bearish.
Out of all of the special options we uncovered, 38 are puts, for a total amount of $4,018,250, and 16 are calls, for a total amount of $699,769.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $200.0 to $290.0 for Humana over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Humana's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Humana's substantial trades, within a strike price spectrum from $200.0 to $290.0 over the preceding 30 days.
<h3>Humana Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734463821_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>HUM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$3.4</td>
<td>$3.1</td>
<td>$3.19</td>
<td>$220.00</td>
<td>$647.5K</td>
<td>1.1K</td>
<td>2.0K</td>
</tr>
<tr>
<td>HUM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$2.5</td>
<td>$1.45</td>
<td>$2.6</td>
<td>$245.00</td>
<td>$527.8K</td>
<td>2.1K</td>
<td>2.1K</td>
</tr>
<tr>
<td>HUM</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$21.8</td>
<td>$19.0</td>
<td>$20.4</td>
<td>$260.00</td>
<td>$306.0K</td>
<td>1.4K</td>
<td>799</td>
</tr>
<tr>
<td>HUM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$22.3</td>
<td>$20.8</td>
<td>$20.4</td>
<td>$260.00</td>
<td>$255.0K</td>
<td>1.4K</td>
<td>926</td>
</tr>
<tr>
<td>HUM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$22.2</td>
<td>$20.2</td>
<td>$21.0</td>
<td>$260.00</td>
<td>$210.0K</td>
<td>1.4K</td>
<td>1.0K</td>
</tr>
</tbody>
</table>

<h3>About Humana</h3>
Humana is one of the largest private health insurers in the us with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Following our analysis of the options activities associated with Humana, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Humana</h3>
<ul>
<li>With a trading volume of 2,664,992, the price of HUM is down by -8.58%, reaching $238.12.</li>
<li>Current RSI values indicate that the stock is may be oversold.</li>
<li>Next earnings report is scheduled for 37 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Humana</h3>
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $301.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Morgan Stanley keeps a Equal-Weight rating on Humana with a target price of $301. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Humana options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Smart Money Is Betting Big In HUM Options

UpHealth (UPHL) has released an update. UpHealth, Inc. announced its agreement to sell Cloudbreak, its subsidiary, to Forest Buyer, LLC for $180 mi...

UpHealth's Strategic Sale of Cloudbreak to Boost Shareholder Value

UpHealth (UPHL) has released an update. UpHealth, Inc. has granted its CEO, Martin Beck, an option to buy 1.3 million shares at $0.385 each, with i...

UpHealth Incentivizes CEO with Stock Option Plan

The latest announcement is out from UpHealth (UPHL). UpHealth, Inc. has solidified its executive leadership structure by revising employment agreem...

UpHealth Revamps Leadership and Enhances Compensation Packages

UpHealth (UPHL) has provided an announcement. UpHealth, Inc. is embroiled in an international arbitration over the control of Glocal Healthcare Sys...

UpHealth Wins Arbitration in Glocal Healthcare Dispute

UpHealth Non-GAAP EPS of -$0.54 misses by $0.17, revenue of $17.35M misses by $15.65M

UpHealth appoints Jay Jennings as acting CEO

An update from UpHealth (UPHL) is now available. UpHealth, Inc. has announced the resignation of its CEO, Martin Beck, effective July 10, 2024, alo...

UpHealth Announces CEO Transition and Board Changes

UPHL

Press Releases

UpHealth Completes Sale of Cloudbreak Health at $180 Million Full Cash Deal

Legal

The International Court of Arbitration awarded UpHealth Holdings more than $110 Million in Damages in Breach of Contract Lawsuit Involving the 2020 Purchase by UpHealth of Glocal Healthcare Systems

Earnings

Health Care

UpHealth Provides Corporate Update and Announces Fourth Quarter and Full Year 2023 Financial Results

UpHealth Holdings Takes Steps to Enforce the International Court of Arbitration's Final Award to UpHealth Holdings of more than $110 Million in Damages in Breach of Contract Lawsuit Involving the 2020 Purchase by UpHealth of Glocal Healthcare Systems

Calcutta High Court rules in favour of UpHealth Holdings, Inc., and vigorously reinforces the ICC International Court of Arbitration previous $110 million award against Glocal directors and other Respondents, calling their conduct "dishonest and fraudulent"

Comments

UpHealth

UpHealth (UPHL) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga